{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,1,15]],"date-time":"2024-01-15T01:58:25Z","timestamp":1705283905075},"reference-count":45,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1016\/j.transproceed.2011.08.103","type":"journal-article","created":{"date-parts":[[2011,12,14]],"date-time":"2011-12-14T05:19:39Z","timestamp":1323839979000},"page":"3824-3828","source":"Crossref","is-referenced-by-count":8,"title":["The Effect and Safety of the Treatment of Recurrent Hepatitis C Infection After Orthotopic Liver Transplantation With Pegylated Interferon \u03b12b and Ribavirin"],"prefix":"10.1016","volume":"43","author":[{"given":"A.","family":"Perrakis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Yedibela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Schuhmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Croner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Schellerer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Demir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Hohenberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2011.08.103_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-2000-9506","article-title":"Epidemiology of hepatitis C: geographic differences and temporal trends","volume":"20","author":"Wasley","year":"2000","journal-title":"Semin Liver Dis"},{"issue":"suppl 1","key":"10.1016\/j.transproceed.2011.08.103_bib2","first-page":"215","article-title":"Natural history of hepatitis C","volume":"26","author":"Seeff","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.transproceed.2011.08.103_bib3","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0140-6736(96)07642-8","article-title":"Natural history of liver fibrosis progression in patients with chronic hepatitis C","volume":"349","author":"Poynard","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.transproceed.2011.08.103_bib4","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1053\/gast.1997.v112.pm9024300","article-title":"Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients","volume":"112","author":"Fattovich","year":"1997","journal-title":"Gastroenterology"},{"issue":"suppl 1","key":"10.1016\/j.transproceed.2011.08.103_bib5","first-page":"344","article-title":"Hepatitis C and hepatocellular carcinoma","volume":"26","author":"Di Biscegile","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.transproceed.2011.08.103_bib8","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1056\/NEJM199603283341302","article-title":"Long-term outcome of hepatitis C infection after liver transplantation","volume":"334","author":"Gane","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.transproceed.2011.08.103_bib9","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/hep.510290122","article-title":"High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: relationship with rejection episodes","volume":"29","author":"Prieto","year":"1999","journal-title":"Hepatology"},{"issue":"10 suppl 1","key":"10.1016\/j.transproceed.2011.08.103_bib10","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1053\/jlts.2002.35861","article-title":"Retransplantation for recurrent hepatitis C","volume":"8","author":"Ghobrial","year":"2002","journal-title":"Liver Transpl"},{"key":"10.1016\/j.transproceed.2011.08.103_bib11","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1046\/j.1365-2893.2000.00202.x","article-title":"Recurrent hepatitis C after liver transplantation: clinical and therapeutical issues","volume":"7","author":"Samuel","year":"2000","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.transproceed.2011.08.103_bib12","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1053\/jhep.2002.33993","article-title":"Contribution of donor age to the recent decrease in patient survival among HCV-infected liver transplant recipients","volume":"36","author":"Berenguer","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.transproceed.2011.08.103_bib13","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1053\/gast.2002.32418","article-title":"The association between hepatitis C infection and survival after orthotopic liver transplantation","volume":"122","author":"Forman","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.transproceed.2011.08.103_bib14","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/hep.1840010511","article-title":"Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis","volume":"1","author":"Knodell","year":"1981","journal-title":"Hepatology"},{"key":"10.1016\/j.transproceed.2011.08.103_bib15","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1053\/he.2000.5789","article-title":"Hemolytic anemia induced by ribavirin therapy in patients with chronic hepatitis C virus infection: role of membrane oxidative damage","volume":"31","author":"De Franceschi","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.transproceed.2011.08.103_bib16","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1053\/jhep.2000.17924","article-title":"Natural history of clinically compensated HCV-related graft cirrhosis following liver transplantation","volume":"32","author":"Berenguer","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.transproceed.2011.08.103_bib17","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/s00423-003-0456-5","article-title":"Liver transplantation for hepatocellular carcinoma: a single European centre experience","volume":"389","author":"Yedibela","year":"2004","journal-title":"Langenbecks Arch Surg"},{"key":"10.1016\/j.transproceed.2011.08.103_bib18","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1002\/hep.510270530","article-title":"A randomized study comparing ribavirin and interferon alfa monotherapy for hepatitis C recurrence after liver transplantation","volume":"27","author":"Gane","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.transproceed.2011.08.103_bib19","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/00007890-200202150-00010","article-title":"Immunological and virological effects of ribavirin in hepatitis C after liver transplantation","volume":"73","author":"Quadri","year":"2002","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2011.08.103_bib20","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1002\/hep.510260236","article-title":"Pilot study of combination of interferon alpha and ribavirin as therapy of recurrent hepatitis C after liver transplantation","volume":"26","author":"Bizollon","year":"1997","journal-title":"Hepatology"},{"issue":"suppl 1","key":"10.1016\/j.transproceed.2011.08.103_bib21","first-page":"265","article-title":"Treatment of recurrent hepatitis C after liver transplantation with interferon alfa 2b and ribavirin [abstract]","volume":"32","author":"Zamboni","year":"2000","journal-title":"J Hepatol"},{"key":"10.1016\/j.transproceed.2011.08.103_bib22","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1053\/jlts.2001.27869","article-title":"Recurrent hepatitis C after liver transplantation: a nonrandomized trial of interferon alfa alone versus interferon alfa and ribavirin","volume":"7","author":"Ahmad","year":"2001","journal-title":"Liver Transpl"},{"key":"10.1016\/j.transproceed.2011.08.103_bib23","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1053\/jlts.2001.27871","article-title":"Combined therapy with interferon and low-dose ribavirin in posttransplantation recurrent hepatitis C: a pragmatic study","volume":"7","author":"Alberti","year":"2001","journal-title":"Liver Transpl"},{"key":"10.1016\/j.transproceed.2011.08.103_bib24","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1097\/00007890-200103150-00019","article-title":"Interferon-\u03b1 and ribavirin for the treatment of recurrent hepatitis C after liver transplantation","volume":"71","author":"De Vera","year":"2001","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2011.08.103_bib25","first-page":"545","article-title":"Combination interferon-alpha and ribavirin for recurrent HCV infection after liver transplantation: a randomized controlled study [abstract]","volume":"32","author":"Samuel","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.transproceed.2011.08.103_bib26","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1053\/gast.2003.50095","article-title":"Interferon-alpha 2b plus ribavirin in patients with chronic hepatitis C after liver transplantation: a randomized study","volume":"124","author":"Samuel","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.transproceed.2011.08.103_bib27","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.1016\/j.transproceed.2003.10.083","article-title":"Pilot study of pegylated interferon alpha-2b and ribavirin for recurrent hepatitis C after liver transplantation","volume":"35","author":"Mukherje","year":"2003","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2011.08.103_bib28","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.jhep.2003.12.015","article-title":"Treatment of recurrent hepatitis C after liver transplantation: a pilot study of peginterferon alpha-2b and ribavirin combination","volume":"40","author":"Dumortier","year":"2004","journal-title":"J Hepatol"},{"key":"10.1016\/j.transproceed.2011.08.103_bib29","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1046\/j.1399-0012.2003.00145.x","article-title":"Pegylated interferon \u03b1-2b plus ribavirin in the treatment of post-liver transplant recurrent hepatitis C","volume":"18","author":"Ross","year":"2004","journal-title":"Clin Transpl"},{"key":"10.1016\/j.transproceed.2011.08.103_bib30","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1586\/egh.10.60","article-title":"Antiviral therapy for hepatitis C is associated with improved clinical outcomes in patients with advanced fibrosis","volume":"4","author":"Russo","year":"2010","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.transproceed.2011.08.103_bib31","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1053\/jlts.2003.50268","article-title":"Report of the first International Liver Transplantation Society expert panel consensus conference on liver transplantation and hepatitis C","volume":"9","author":"Wiesner","year":"2003","journal-title":"Liver Transpl"},{"key":"10.1016\/j.transproceed.2011.08.103_bib32","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/hep.20560","article-title":"Pegasys Transplant Study Group Peginterferon alfa-2a for hepatitis C after liver transplantation: two randomized, controlled trials","volume":"41","author":"Chalasani","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.transproceed.2011.08.103_bib33","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1600-6143.2006.01590.x","article-title":"Rejection under alpha interferon therapy in liver transplant recipients","volume":"7","author":"Walter","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2011.08.103_bib34","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1399-0012.2009.01201.x","article-title":"Antiviral re-treatment of IFN-ribavirin non-responders for recurrent post-transplantation hepatitis C","volume":"25","author":"Yedibela","year":"2010","journal-title":"Clin Transplant"},{"key":"10.1016\/j.transproceed.2011.08.103_bib35","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1002\/hep.1840220411","article-title":"An open trial of interferon-\u03b1 recombinant for hepatitis C after liver transplantation","volume":"22","author":"Feray","year":"1995","journal-title":"Hepatology"},{"key":"10.1016\/j.transproceed.2011.08.103_bib36","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/j.1478-3231.2005.1065.x","article-title":"Successful treatment of hepatitis C reinfection with interferon-alpha2b and ribavirin after liver transplantation","volume":"25","author":"Yedibela","year":"2005","journal-title":"Liver Int"},{"key":"10.1016\/j.transproceed.2011.08.103_bib37","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1053\/gast.2003.50095","article-title":"Interferon-alpha 2b plus ribavirin in patients with chronic hepatitis C after liver transplantation: a randomized study","volume":"124","author":"Samuel","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.transproceed.2011.08.103_bib38","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1002\/lt.20883","article-title":"Clinical and histological efficacy of pegylated interferon and ribavirin therapy of recurrent hepatitis C after liver transplantation","volume":"12","author":"Fern\u00e1ndez","year":"2006","journal-title":"Liver Transpl"},{"key":"10.1016\/j.transproceed.2011.08.103_bib39","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1002\/lt.21121","article-title":"Sustained virologic response to therapy of recurrent hepatitis C after liver transplantation is related to early virologic response and dose adherence","volume":"13","author":"Sharma","year":"2007","journal-title":"Liver Transpl"},{"key":"10.1016\/j.transproceed.2011.08.103_bib40","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1053\/j.gastro.2007.03.041","article-title":"Efficacy of antiviral therapy on hepatitis C recurrence after liver transplantation: a randomized controlled study","volume":"132","author":"Carri\u00f3n","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.transproceed.2011.08.103_bib41","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1046\/j.1399-0012.2003.00145.x","article-title":"Pegylated interferon alpha-2b plus ribavirin in the treatment of post-liver transplant recurrent hepatitis C","volume":"18","author":"Ross","year":"2004","journal-title":"Clin Transplant"},{"key":"10.1016\/j.transproceed.2011.08.103_bib42","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1478-3231.2006.01261.x","article-title":"Impact of pegylated interferon alpha-2B and ribavirin on hepatic fibrosis in liver transplant patients with recurrent hepatitis C: an open-label series","volume":"26","author":"Mukherjee","year":"2006","journal-title":"Liver Int"},{"key":"10.1016\/j.transproceed.2011.08.103_bib43","first-page":"561","article-title":"Impact of pegylated interferon alfa-2a and ribavirin on hepatic fibrosis inliver transplant patients with recurrent hepatitis C: an open-label series","volume":"53","author":"Mukherjee","year":"2006","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.transproceed.2011.08.103_bib44","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/j.1600-6143.2006.01619.x","article-title":"Histological benefit of retreatment by pegylated interferon alfa-2b and ribavirin in patients with recurent hepatitis C virus infection posttransplantation","volume":"7","author":"Bizollon","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2011.08.103_bib45","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1097\/01.TP.0000129811.93072.1C","article-title":"Treatment of established recurrent hepatitis C in liver-transplant recipients with pegylated interferon-alfa-2b and ribavirin therapy","volume":"78","author":"Neff","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2011.08.103_bib46","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1053\/j.gastro.2009.08.071","article-title":"Randomized study of peginterferon-alpha2a plus ribavirin vs peginterferon-alpha2b plus ribavirin in chronic hepatitis C","volume":"138","author":"Rumi","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.transproceed.2011.08.103_bib47","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/j.1440-1746.2005.03795.x","article-title":"Pegylated versus standard interferon-alpha in antiviral regimens for post-transplant recurrent hepatitis C: Comparison of tolerability and efficacy","volume":"20","author":"Toniutto","year":"2005","journal-title":"J Gastroenterol Hepatol"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134511012851?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134511012851?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,20]],"date-time":"2019-06-20T22:19:36Z","timestamp":1561069176000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134511012851"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":45,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S0041134511012851"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2011.08.103","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}